Neuvasq Biotechnologies

Developer of therapeutics for acute neurological disorders and neurodegenerative diseases

placeCharleroi, Wallonia, Belgium calendar_todayFounded 2021 groups3 employees language neuvasq.com

Registered entities

Social engagement

Social engagement: 1.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Newton Biocapital.

Investor typeCountShare
Venture capital350%
Private equity350%

Recent activity

17 Jun 2026
Event
BioBiz Buzz discussion on Wnt/-catenin signaling in barrier endothelial cells
15 Jun 2026
Event
BIO International Convention 2026
1 Jun 2026
Product launch
NVQ501 trispecific approach
Coming soon